+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Global Recombinant Protein Market Outlook 2020: Global Opportunity and Demand Analysis, Market Forecast, 2020-2028

  • ID: 5572568
  • Report
  • March 2022
  • Region: Global
  • 124 Pages
  • Insure Insights
The growth of the recombinant protein market is attributed to increased expenditure in R & D, the growing prevalence of chronic diseases, a rising inclination toward biologics and biosimilars, and advanced recombinant products. The global recombinant protein market was valued at the US $347.2 million in 2019 and is predicted to witness a strong CAGR of 6.2% over the forecast period 2019-2028. Recombinant proteins are used in the development of novel therapies for severe chronic diseases such as cancer and other rare diseases. Recombinant protein production requires a special technique known as recombinant DNA (rDNA) technology. Depending on the type of the protein, recombinant proteins are classified into hormones, growth factors, cytokines, plasma protein factors, recombinant metabolic enzymes, and others.

Top Driver: Growing demand for ready-to-eat food will drive the market's growth.

The recombinant proteins market is anticipated to grow in the forecast period owing to driving factors such as growing research and development expenditure on biological drugs, technological advancement in the production of recombinant proteins, and demand for recombinant therapeutic proteins. However, the complex manufacturing process, higher costs, and requirement for the top quality of those products eventually hinder the market's growth. R & D is defined as the process of creating new products, processes, and technologies that can be used and marketed for mankind’s benefit in the future. New drugs serving unmet medical needs are one of the key value drivers for research-based pharmaceutical companies. The rate of growth in R & D funding in 2015 and the location of that growth are both significant. Trends are showing a return to growth, with only minor caution, across most areas of R & D spending. The increase in R & D investment in Asia, particularly China, and the consecutive annual growth in R & D spending in North America indicates a period of stability, security, and healthy competition across industrial sectors.

Research & development expenditure on biological drugs Make Crucial Contribution to Growth of Global Recombinant protein Market

Biopharmaceutical organizations are focusing on research and development of novel biosimilars for life-threatening diseases such as cardiovascular diseases, cancer, metabolic disorders such as diabetes, and certain rare conditions such as hemophilia. According to Pharmaceutical Research and Manufacturers of America (PhRMA), in 2016, member companies invested around US $58.8 billion in research and development 2015, of which a majority was by all biopharmaceutical companies in the U.S. Rare disease medical space holds potential as there's relatively low competition. This is owing to less understanding of the disease progression pathways and entities. Therefore, companies could focus on R&D for the development of biologics and, subsequently, biosimilars in this space. Some of the biosimilars available on the market include Eprex, manufactured by Janssen-Cilag Pty Ltd., which has been successful in the treatment of anemia. Demand for biosimilars is increasing significantly, owing to the high prices of biologics, which in turn leads to high demand for recombinant proteins.

Biopharmaceutical organizations are focusing on research and development of novel biosimilars for life-threatening diseases such as cardiovascular diseases, cancer, metabolic disorders such as diabetes, and certain rare conditions such as hemophilia. According to Pharmaceutical Research and Manufacturers of America (PhRMA), in 2016, member companies invested around the US $58.8 billion in research and development in 2015, of which a majority was by all biopharmaceutical companies in the U.S. Rare disease medical space holds potential as there's relatively low competition. This is owing to less understanding of the disease progression pathways and entities. Therefore, companies could focus on R&D for the development of biologics and, subsequently, biosimilars in this space. Some of the biosimilars available on the market include Eprex, manufactured by Janssen-Cilag Pty Ltd., which has been successful in the treatment of anemia. Demand for biosimilars is increasing significantly, owing to the high prices of biologics, which in turn leads to high demand for recombinant proteins.

North American Region Holds the Largest Market Share in the Global Recombinant protein Market

Due to the increasing expenditure on research, North America is predicted to steer the worldwide recombinant protein market. The United States is anticipated to witness the highest growth, owing to the largest concentration of world-class research universities and academic medical centers. In the North American region, the United States holds the largest market share due to factors such as an increasing number of chronic diseases and a growing number of research and development programs in the country. Good funding from the government to small and medium enterprises involved in recombinant developments, followed by a good distribution channel of the companies with hospitals, is expected to drive the market in the region.

Players to Focus on Recombinant protein Market

The recombinant protein market consists of several major players, including

  • Eli Lilly and Company
  • Merck KGaA
  • Novo Nordisk AS
  • Abcam Merck
  • Bioscience, Inc.
  • ProSpec Tany TechnoGene, Ltd.
  • BPS Bioscience, Inc.
  • Sigma Aldrich Company Ltd.
  • Novoprotein Scientific
  • PeproTech, Inc.

Among others. The companies are implementing certain strategic initiatives, like mergers, new product launches, acquisitions, and partnerships, which help them in strengthening their market position.

Abcam Merck: For instance, in July 2018, Abcam Merck together produced a PD-L1 antibody for immuno-oncology research.

Scope of the Report


By Food

  • Animal Food
  • Human Food
  • Agriculture
  • Pharmaceuticals

By Application

  • Basic Research & Development
  • Biotechnology
  • Drug discovery

By Region

  • North America
  • Europe
  • Asia Pacific
  • Rest Of The World

Key Reasons to Purchase this Report


1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis of changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.
Note: Product cover images may vary from those shown

Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation
Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted
Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary
Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis
Chapter 5 Global Recombinant protein Market Forces
5.1 What’s Driving the Market
5.2 Porter’s Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition
Chapter 6 Global Recombinant protein Market -Industry Snapshots
6.1 Overview
6.1.1 Global Recombinant protein Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis
Chapter 7 Global Recombinant protein Market Analysis, by Food
7.1 Overview
7.2 Key Findings for Recombinant protein Market- By Food
7.2.1 Recombinant protein Market- Animal Food
7.2.2 Recombinant protein Market- Human Food
7.2.3 Recombinant protein Market- Agriculture
Chapter 8 Global Recombinant protein Market Analysis, by Application
8.1 Overview
8.2 Key Findings for Recombinant protein Market- By Product Type
8.2.1 Recombinant protein Market- Basic Research & Development
Recombinant protein market by Product Type 1, 2019 - 2028 (USD Million)
8.2.2 Recombinant protein Market- Biotechnology
Recombinant protein market by Product Type 2, 2019 - 2028 (USD Million)
8.2.3 Recombinant protein Market- Drug discovery
Chapter 9 Recombinant protein Market Analysis by Region
9.1 Key Findings for Recombinant protein Market- By region
9.2 Overview
9.2.1 Global Recombinant protein Market Analysis, By Type, 2019 - 2028
9.2.2 Global Recombinant protein Market Analysis, By Product Type, 2019 - 2028
9.3 Recombinant protein Market - North America
9.3.1 Overview
9.3.2 U.S.
9.3.3 Canada
9.3.4 Mexico
9.3.5 North America Market, By Type
9.3.6 North America Market, By Product Type
9.4 Recombinant protein Market - Europe
9.4.1 Overview
9.4.2 Germany
9.4.3 United Kingdom
9.4.4 France
9.4.5 Italy
9.4.6 Rest Of Europe
9.4.7 Europe Market, By Type
9.4.8 Europe Market, By Product Type
9.5 Recombinant protein Market - Asia Pacific
9.5.1 Overview
9.5.2 China
9.5.3 Japan
9.5.4 India
9.5.5 Rest of APAC
9.5.6 Asia Pacific Market, By Type
9.5.7 Asia Pacific Market, By Product Type
9.6 Recombinant protein Market - Rest Of The World
9.6.1 Overview
9.6.2 Middle East & Africa (MEA)
9.6.3 South America
9.6.4 Rest Of World
9.6.5 South America, Middle East and Africa Market, By Type
9.6.6 South America, Middle East and Africa Market, By Product Type
Chapter 10 Market Competition Analysis
10.1 Market Share/Positioning Analysis
10.1.1 Market Positioning of Key Vendors, 2019
10.1.2 Key Strategies Adopted by the Leading Players
10.1.3 Recent Developments
Chapter 11 Company Profiles- Snapshot
11.1 GenScript Biotech Corporation Business Fundamentals
11.1.1 Financial Snapshots
11.1.2 Product Portfolio
11.1.3 Recent Developments
11.2 Eli Lilly and Company
11.3 Merck KGaA
11.4 Novo Nordisk AS
11.5 Abcam Merck
11.6 Bioscience, Inc.
11.7 ProSpec Tany TechnoGene, Ltd.
11.8 BPS Bioscience, Inc.
11.9 Sigma Aldrich Company Ltd.
11.10 Novoprotein Scientific
11.11 PeproTech, Inc.
11.12 Feldan Bio, Inc.
11.13 BioVision, Inc.
11.14 HumanZyme, Inc.
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies"
Chapter 12 Appendix
List of Tables
Table 1 Recombinant protein market by Food 1, 2019 - 2028 (USD Million)
TABLE 2 Recombinant protein market by Food 2, 2019 - 2028 (USD Million)
TABLE 3 Recombinant protein market by Food 3, 2019 - 2028 (USD Million)
TABLE 4 Recombinant protein market by Product Type 3, 2019 - 2028 (USD Million)
TABLE 5 Global Recombinant protein Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 6 Global Recombinant protein Market Value, By Product Type, 2019 - 2028 (US$ Bn)
TABLE 7 Recombinant protein Market Analysis by North America (USD Million), 2019 - 2028
TABLE 8 U.S. Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 9 U.S. Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 10 U.S. Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 11 Canada Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 12 Canada Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 13 Canada Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 14 Mexico Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 15 Mexico Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 16 Mexico Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 17 Recombinant protein Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 18 Germany Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 19 Germany Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 20 Germany Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 21 United Kingdom Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 22 United Kingdom Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 23 United Kingdom Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 24 France Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 25 France Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 26 France Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 27 Italy Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 28 Italy Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 29 Italy Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 30 Rest Of Europe Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 31 Rest Of Europe Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 32 Rest Of Europe Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 33 Recombinant protein Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 34 China Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 35 China Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 36 China Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 37 Japan Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 38 Japan Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 39 Japan Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 40 India Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 41 India Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 42 India Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 43 Rest of APAC Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 44 Rest of APAC Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 45 Rest of APAC Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 46 Recombinant protein Market Analysis by Rest Of The World (USD Million), 2019 - 2028
TABLE 47 Middle East & Africa (MEA) Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 48 Middle East & Africa (MEA) Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 49 Middle East & Africa (MEA) Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 50 South America Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 51 South America Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 52 South America Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
TABLE 53 Rest Of World Recombinant protein Market, 2019 - 2028 (USD Million)
TABLE 54 Rest Of World Recombinant protein Market, By Type, 2019 - 2028 (USD Million)
TABLE 55 Rest Of World Recombinant protein Market, By Product Type, 2019 - 2028 (USD Million)
List of Figures
Figure 1 Global Recombinant protein : Market Segmentation
Figure 2 Global Recombinant protein Market: Research Methodology
Figure 3 Top-Down and Bottom Up Approach
Figure 4 Market Snapshot
Figure 5 Porter’s Five Forces Analysis
Figure 6 Global Recombinant protein Market Value, 2019 - 2028, (US$ Bn)
Figure 7 Supply Chain/Value Chain Analysis
Figure 8 Global Recombinant protein Market Value Contribution, By Type, 2019 & 2026 (%)
Figure 9 Global Recombinant protein Market Value Contribution, By Product Type, 2019 & 2026 (%)
Figure 10 Global Recombinant protein Market Value, 2019 - 2028, (US$ Bn)
Figure 11 North America Recombinant protein Market Value, 2019 - 2028, (US$ Bn)
Figure 12 Recombinant protein Market Segment 1 – North America
Figure 13 Recombinant protein Market Segment 2 – North America
Figure 14 Recombinant protein U.S. outlook, 2019 & 2026
Figure 15 Recombinant protein Canada outlook, 2019 & 2026
Figure 16 Recombinant protein Mexico outlook, 2019 & 2026
Figure 17 Europe Recombinant protein Market Value, 2019 - 2028, (US$ Bn)
Figure 18 Recombinant protein Market Segment 1 – Europe
Figure 19 Recombinant protein Market Segment 2 – Europe
Figure 20 Recombinant protein Germany outlook, 2019 & 2026
Figure 21 Recombinant protein United Kingdom outlook, 2019 & 2026
Figure 22 Recombinant protein France outlook, 2019 & 2026
Figure 23 Recombinant protein Italy outlook, 2019 & 2026
Figure 24 Recombinant protein Rest Of Europe outlook, 2019 & 2026
Figure 25 Asia Pacific Recombinant protein Market Value, 2019 - 2028, (US$ Bn)
Figure 26 Recombinant protein Market Segment 1 – Asia Pacific
Figure 27 Recombinant protein Market Segment 2 – Asia Pacific
Figure 28 Recombinant protein China outlook, 2019 & 2026
Figure 29 Recombinant protein Japan outlook, 2019 & 2026
Figure 30 Recombinant protein India outlook, 2019 & 2026
Figure 31 Recombinant protein Rest of APAC outlook, 2019 & 2026
Figure 32 Rest Of The World Recombinant protein Market Value, 2019 - 2028, (US$ Bn)
Figure 33 Recombinant protein Market Segment 1 – Rest Of The World
Figure 34 Recombinant protein Market Segment 2 – Rest Of The World
Figure 35 Recombinant protein Middle East & Africa (MEA) outlook, 2019 & 2026
Figure 36 Recombinant protein South America outlook, 2019 & 2026
Figure 37 Recombinant protein Rest Of World outlook, 2019 & 2026
Note: Product cover images may vary from those shown

Loading
LOADING...